Annette Clancy

Senior Advisor

Annette is a Senior Advisor on the Frazier Life Sciences team with over 30 years of R&D, business development and commercial experience to help evaluate new deals and advise portfolio companies.

Annette joined Frazier Healthcare Partners in 2009 as a Senior Advisor. She provides strategic guidance for both new and existing Life Sciences investments, and based in London, also serves as the team’s primary contact in Europe.

Annette has over 30 years of experience in the global pharmaceutical industry, predominantly with GlaxoSmithKline (GSK). She has served in a number of roles with GSK in the US and UK, including positions in R&D, worldwide strategic marketing, and licensing / business development. She served as GSK’s Head of Global Transactions and Alliance Management until her retirement in 2008, executing innovative deals ranging from early drug discovery partnerships, to global commercial alliances, to mergers and acquisitions.

In addition to her role at Frazier, Annette serves as a non-executive director at multiple private and public European Life Sciences companies. She Chairs the Board at Genable, Obseva, and Lysogene, and is a non-executive director at Swedish Orphan Biovitrum (STO: SOBI).

Annette holds a B.Sc. (hons) in Pharmacology from Bath University.




Bath University (B.Sc.)

Year Joined